8888
Active member
If any of you are subscribed to the International Hyperhidrosis Society newsletter they mentioned Benztropine as a possible treatment however it was for Anti-depressant induced sweating but it should work for all sweating situations? maybe? http://www.sweathelp.org
Copied from newsletter:
According to the National Center for Health Statistics, more than 1 in 10 adults in the U.S. is taking an antidepressant. Twenty-two percent of these people, reports Dr. Scarff, experience excessive sweating as a side-effect of their medication. This type of sweating is called secondary hyperhidrosis (as opposed to primary hyperhidrosis, which is a medical condition unto itself). The unpleasant sweating that is secondary to antidepressants may be severe enough for patients to discontinue their treatment (with obvious negative impacts). Preserving the benefits of antidepressant treatment while counteracting untoward sweating is therefore an important goal. A goal which Dr. Scarff suggests can be reached through the use of oral agents. He writes: “Although evidence is limited to case reports, consider cholinergic and serotonergic antagonists and dopamine partial agonists to relieve antidepressant-induced diaphoresis [excessive sweating].”
Specifically, Dr. Scarff has found that the anticholinergic benztropine reduced or eliminated antidepressant-related sweating with doses ranging from 0.5 mg every other day to 1 mg/day. Dry mouth was the only reported side-effect.
Other medications recommended by Dr. Scarff include: cyproheptadine (mild sedation reported as a side-effect), mirtazapine and aripiprazole.
Copied from newsletter:
According to the National Center for Health Statistics, more than 1 in 10 adults in the U.S. is taking an antidepressant. Twenty-two percent of these people, reports Dr. Scarff, experience excessive sweating as a side-effect of their medication. This type of sweating is called secondary hyperhidrosis (as opposed to primary hyperhidrosis, which is a medical condition unto itself). The unpleasant sweating that is secondary to antidepressants may be severe enough for patients to discontinue their treatment (with obvious negative impacts). Preserving the benefits of antidepressant treatment while counteracting untoward sweating is therefore an important goal. A goal which Dr. Scarff suggests can be reached through the use of oral agents. He writes: “Although evidence is limited to case reports, consider cholinergic and serotonergic antagonists and dopamine partial agonists to relieve antidepressant-induced diaphoresis [excessive sweating].”
Specifically, Dr. Scarff has found that the anticholinergic benztropine reduced or eliminated antidepressant-related sweating with doses ranging from 0.5 mg every other day to 1 mg/day. Dry mouth was the only reported side-effect.
Other medications recommended by Dr. Scarff include: cyproheptadine (mild sedation reported as a side-effect), mirtazapine and aripiprazole.